Lutetium-(177Lu)-Oxodotreotid (1) – Lutathera®

Radiotherapy

Characteristics

Start date 29.08.2017
Resolution 19.10.2017
INN Lutetium-(177Lu)-Oxodotreotid
Brand name Lutathera®
Pharm. company Advanced Accelerator Applications Germany GmbH
G-BA Procedure ID F-003
ATC code V10XX04 Various therapeutic radiopharmaceuticals (V10XX)
Therapeutic area Oncological diseases Neuroendocrine tumors (NET) Orphan
Reason for procedure not completed: exempted

Associated procedures

Lutetium-(177Lu)-Oxodotreotid (1) Lutathera® Advanced Accelerator Applications Germany GmbH Oncological diseases Radiotherapy n.d. exempted Orphan


<< List of all resolutions